Skip to content
PICO Portalanswers from OpenAlex

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment

PaperCitations, authors & open-access status

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment is a paper indexed in PICO Portal from OpenAlex.

How many citations does Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment have?

PICO Portalcitation count

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment has 319 citations in the OpenAlex counts PICO Portal stores.

When was Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment published?

PICO Portalyear

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment has 2009 year in the PICO Portal index.

What is the open-access status of Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment?

PICO Portaloa status

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment has closed oa status in the PICO Portal index.

What is the DOI of Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment?

PICO Portaldoi

The DOI for Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment is on the source record.

What is the PMID of Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment?

PICO Portalpmid

The PMID for Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment is on the source record.

What is the OpenAlex record for Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment?

PICO Portalopenalex

The OpenAlex for Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial